← back to search

Michelle Lee

Harvard University · US
Area of research
Genetics · Hematology
Research interest
Research interests include Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, and Chronic Lymphocytic Leukemia Research.
h-index
37
citations
8,578
works
188
NIH funding
primary concept
email

Recent publications

Impact of statin use on cardiovascular and hematologic outcomes among patients with myeloproliferative neoplasms.
2026cited by 1position: contributordoi
Myeloproliferative neoplasm subtypes have distinct impact on risk of incident osteoporosis and osteoporotic fractures.
2026cited by 0position: contributordoi
Real-world outcomes of hybrid obesity care using digital coaching and GLP-1 therapy in a multi-ethnic Asian setting
International Journal of Obesity 2026cited by 0position: contributordoi
Low Serum Cholesterol Is a Biomarker of Advanced Disease and Poor Outcomes in Myeloproliferative Neoplasms.
2026cited by 0position: contributordoi
Characterization and prognostic implication of pulmonary hypertension among patients with myeloproliferative neoplasms
Haematologica 2025cited by 6position: middledoi
Impact of Echocardiographic Probability of Pulmonary Hypertension on Prognosis and Outcomes Among Patients With Myeloproliferative Neoplasms.
2025cited by 2position: contributordoi
Psychiatric and substance use disorders predict poor outcomes in older veterans with acute myeloid leukemia.
2025cited by 0position: contributordoi
Myeloproliferative Neoplasms and Cardiovascular Disease: A Review
Current Treatment Options in Oncology 2024cited by 9position: middledoi
Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer
JAMA Network Open 2024cited by 8position: middledoi
Nivolumab in Patients With Advanced or Metastatic Malignancies, Including Rare Cancers: Results of CheckMate 627, an Adaptive Basket Design Clinical Trial
JCO oncology advances. 2024cited by 3position: middledoi
Metformin for MPN: teaching an old drug new tricks.
2024cited by 1position: contributordoi
Erythroid variant evolving from chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitors: a rare case report.
2024cited by 0position: contributordoi
Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study — United States, August 19, 2022–March 31, 2023
MMWR Morbidity and Mortality Weekly Report 2023cited by 178position: middledoi
Rilzabrutinib <i>versus</i> placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study
Therapeutic Advances in Hematology 2023cited by 32position: middledoi
Baseline correlates of frailty and its association with survival in United States veterans with acute myeloid leukemia.
2023cited by 2position: contributordoi
WHIM Syndrome: First Reported Case in a Patient of African Ancestry.
2023cited by 1position: contributordoi
Safety and Efficacy of Propylene Glycol-Free Melphalan in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Results of a Phase II Study.
2023cited by 0position: contributordoi
Small cell lung cancer in young patients: trends in sociodemographic factors, diagnosis, treatment, and survival
Journal of Thoracic Disease 2022cited by 11position: firstdoi
Small cell lung cancer in young patients: trends in sociodemographic factors, diagnosis, treatment, and survival.
2022cited by 5position: contributordoi
Pre-Clinical Activity of Amino-Alcohol Dimeric Naphthoquinones as Potential Therapeutics for Acute Myeloid Leukemia.
2022cited by 2position: contributordoi
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.
2019cited by 1,027position: contributordoi
Analysis of the Mechanisms of Action of Naphthoquinone-Based Anti-Acute Myeloid Leukemia Chemotherapeutics.
2019cited by 11position: contributordoi
A New Brain Mass in an Immunocompromised Woman.
2019cited by 0position: contributordoi
Enhanced Water Barrier Properties of Surfactant-Free Polymer Films Obtained by MacroRAFT-Mediated Emulsion Polymerization
ACS Applied Materials & Interfaces 2018cited by 61position: middledoi
AMPAkines Target the Nucleus Accumbens to Relieve Postoperative Pain
Anesthesiology 2016cited by 23position: middledoi
Activation of Corticostriatal Circuitry Relieves Chronic Neuropathic Pain
Journal of Neuroscience 2015cited by 264position: firstdoi
Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes
Science 2014cited by 558position: middledoi
Blood Kidney Injury Molecule-1 Is a Biomarker of Acute and Chronic Kidney Injury and Predicts Progression to ESRD in Type I Diabetes
Journal of the American Society of Nephrology 2014cited by 460position: middledoi
Intersection of population variation and autoimmunity genetics in human T cell activation
Science 2014cited by 264position: middledoi
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Nature Genetics 2013cited by 1,435position: middledoi

Grants

SBIR Phase I: Delivering living probiotic cells in topical skin application
NSF2035984$256,0002021–2022PIRePORTER

Frequent collaborators

· 3 papers (2023–2026)Philip L. De Jager · Mayo Clinic in Florida3 papers (2013–2014)Jing Wang · Shandong University of Traditional Chinese Medicine3 papers (2013–2016)Chen Su · New York University2 papers (2015–2016)James A. D’amour · New York University2 papers (2013–2015)Nathaniel R. Smilowitz · NYU Langone Health2 papers (2025–2025) · 2 papers (2024–2025)Runtao Yang · New York University2 papers (2015–2016)Robert C. Froemke · New York University2 papers (2013–2015)Binita Shah · Insmed (United States)2 papers (2025–2025)Towfique Raj · Mount Sinai Beth Israel2 papers (2013–2014)Gabriela Hobbs · Incyte (United States)2 papers (2024–2025)Duo Xu · University of Wisconsin–Madison2 papers (2013–2016)Mary T. Brophy · Boston University2 papers (2023–2024)Olivia Liu · New York University2 papers (2024–2025)Orly Leiva · University of Kentucky2 papers (2024–2025)Sarah E. Eberle · New York University2 papers (2013–2015)Ting Feng · University of Alabama at Birmingham1 papers (2014–2014)Sahil Sharma · McGill University1 papers (2014–2014)Chang Wang · Sun Yat-sen University1 papers (2014–2014)